切换至 "中华医学电子期刊资源库"

中华诊断学电子杂志 ›› 2018, Vol. 06 ›› Issue (04) : 277 -280. doi: 10.3877/cma.j.issn.2095-655X.2018.04.014

所属专题: 专题评论 文献

方法与技术

促甲状腺激素即时检测技术的临床诊断价值评估
徐家蓉1, 金晖2, 潘明麟1, 缪珩3,()   
  1. 1. 210011 南京医科大学第二附属医院内分泌科
    2. 210009 南京,东南大学附属中大医院内分泌科
    3. 210011 南京医科大学第二附属医院内分泌科;210032 南京市浦口医院内分泌科
  • 收稿日期:2018-03-15 出版日期:2018-11-26
  • 通信作者: 缪珩

Evaluation of clinical diagnostic value of a novel point of care testing for thyroid stimulating hormone

Jiarong Xu1, Hui Jin2, Minglin Pan1, Heng Miao3,()   

  1. 1. Department of Endocrinology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, China
    2. Department of Endocrinology, the Affiliated Zhongda Hospital of Southeast University, Nanjing 210009, China
    3. Department of Endocrinology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, China;Department of Endocrinology, Nanjing Pukou Hospital, Nanjing 210032, China
  • Received:2018-03-15 Published:2018-11-26
  • Corresponding author: Heng Miao
  • About author:
    Corresponding author: Miao Heng, Email:
引用本文:

徐家蓉, 金晖, 潘明麟, 缪珩. 促甲状腺激素即时检测技术的临床诊断价值评估[J]. 中华诊断学电子杂志, 2018, 06(04): 277-280.

Jiarong Xu, Hui Jin, Minglin Pan, Heng Miao. Evaluation of clinical diagnostic value of a novel point of care testing for thyroid stimulating hormone[J]. Chinese Journal of Diagnostics(Electronic Edition), 2018, 06(04): 277-280.

目的

探讨促甲状腺激素(TSH)即时检测(POCT)技术—"TSH闪测卡"的临床效果。

方法

选取2014年9月至2015年2月分别就诊于南京医科大学第二附属医院内分泌科(n=120例)和东南大学附属中大医院内分泌科(n=120例),并需要进行甲状腺功能检测的受试者共240例,收集受试者的指尖血和静脉血样本,分别进行TSH水平的即时定性检测(TSH闪测卡)和电化学发光法的定量检测,以高于TSH定量方法检测的正常值范围上限转换为阳性结果,以介于正常值范围或低于正常值范围下限转换为阴性结果。对测得的结果分别进行配对卡方检验和Kappa一致性检验,比较两种检测方法的差异性和一致性。

结果

TSH闪测卡测得阳性结果共计122例,阴性结果共计118例;电化学发光法测得阳性结果共计120例,阴性结果共计120例;其中两种检测方法均为阳性者有119例,不一致者共有4例。两种方法阳性率比较差异无统计学意义(χ2=1.00,P>0.05),阳性一致性为99.17%(95%CI:97.54%~100.00%),阴性一致性为97.50%(95%CI:94.71%~100.00%),总一致性为98.33%(95%CI:96.71%~99.95%),Kappa值为0.97(95%CI:0.93~1.00),两种方法检测结果一致性极强(χ2=224.33,P<0.01)。

结论

TSH闪测卡定性检测与TSH电化学发光法定量检测技术具有极高的临床一致性,其可用于甲状腺功能减退或亚临床甲状腺功能减退患者的初筛检测,亦可用于甲状腺功能减退患者慢病治疗过程中的及时监测,为基层医疗机构提供新的诊断工具。

Objective

To evaluate the clinical efficacy of the latest thyroid stimulating hormone (TSH) point of care testing (POCT) technology-the "TSH flash card" by comparing with the TSH electrochemiluminescence quantitative detection technique.

Methods

Two hundred and forty cases who required for TSH detection from September 2014 to February 2015 in the Second Affiliated Hospital of Nanjing Medical University (n=120) and the Affiliated Zhongda Hospital of Southeast University (n=120) were enrolled. The tip of finger blood and venous blood samples of the subjects were collected for instant qualitative detection (TSH flash card) and quantitative detection of TSH level by electrochemiluminescence, in which the upper limit of normal value range detected by quantitative TSH method was converted to positive results, and the lower limit of normal value range or below normal value range was converted to negative results. Paired chi-square test and Kappa consistency test were respectively carried out to compare the difference and consistency of the two detection methods.

Results

A total of 122 positive results and 118 negative results of TSH flash cards were obtained. Simultaneously, there were 120 positive results and 120 negative results by electrochemiluminescence. There were 119 cases in which the two methods were positive and 4 cases were inconsistency. There was no statistical difference in the positive rate of the two methods (χ2=1.00, P>0.05). The positive consistency was 99.17% (95%CI: 97.54%-100.00%), the negative consistency was 97.50%(95%CI: 94.71%-100.00%) and the total consistency was 98.33%(95%CI: 96.71%-99.95%). The value of Kappa was 0.97 (95%CI: 0.93-1.00), showing good consistency between the two methods (χ2=224.33, P<0.01).

Conclusions

The TSH flash card method shows good consistency compared with the TSH electrochemiluminescence method. This method can be used for primary screening of hypothyroidism or subclinical hypothyroidism, and it can also provide timely monitoring of patients with hypothyroidism during the treatment of chronic disease, providing a new diagnostic tool for grassroots medical systems.

图1 TSH闪测卡使用示意图
图2 TSH闪测卡和电化学发光法检测TSH水平结果频数分布图
表1 TSH闪测卡与电化学发光法检测TSH水平比较(例)
[1]
中华医学会内分泌学分会. 成人甲状腺功能减退症诊治指南[J]. 中华内分泌代谢杂志, 2017, 33(2): 167-180.
[2]
周蕾,杨瑞馥. 从定性到定量的转变是POCT发展历程中的重要挑战[J]. 中华检验医学杂志, 2014, 37(11): 801-803.
[3]
中华医学会内分泌学分会. 成人甲状腺功能减退症诊治指南[J]. 中华内分泌代谢杂志, 2017, 33(2): 167-180.
[4]
Shan Z,Chen L,Lian X, et al.Iodine status and prevalence of thyroid disorders after introduction of mandatory universal salt iodization for 16 years in China:a cross-sectional study in 10 cities[J]. Thyroid, 2016, 26(8): 1125-1130.
[5]
杨柯君. 我国甲状腺病患者人数量或超2亿[J]. 上海医药, 2013, 34(12): 44.
[6]
Rodondi N,den Elzen WP,Bauer DC.et al.Subclinical hypothyroidism and the risk of coronary heart disease and mortality[J]. JAMA, 2010, 304(12): 1365-1374.
[7]
Collet TH,Bauer DC,Cappola AR.et al.Thyroid antibody status, subclinical hypothyroidism, and the risk of coronary heart disease:an individual participant data analysis[J]. J Clin Endocrinol Metab, 2014, 99(9): 3353-3362.
[8]
Mansournia N,Riyahi S,Tofangchiha S, et al.Subclinical hypothyroidism and diabetic nephropathy in Iranian patients with type 2 diabetes[J]. J Endocrinol Invest, 2017, 40(3): 289-295.
[9]
Casey BM,Thom EA.Subclinical hypothyroidism or hypothyroxinemia in pregnancy[J]. N Engl J Med, 2017, 377(7): 701.
[10]
Hernández M,López C,Soldevila B, et al.Impact of TSH during the first trimester of pregnancy on obstetric and fetal complications:usefulness of 2.5 mIU/L cut-off value[J]. Clin Endocrinol (Oxf), 2018, 88(5): 728-734.
[11]
Sara JD,Zhang M,Gharib H, et al.Hypothyroidism is associated with coronary endothelial dysfunction in women[J] .J Am Heart Assoc, 2015, 4(8): e002225.
[12]
Carty DM,Doogan F,Welsh P, et al.Thyroid stimulating hormone (TSH)≥2.5mU/l in early pregnancy: prevalence and subsequent outcomes[J]. Eur J Obstet Gynecol Reprod Biol, 2017(210): 366-369.
[13]
王绍宁. 左甲状腺素钠治疗老年甲状腺功能减退症的疗效及安全性分析[J]. 当代医学, 2017, 23(24): 32-35.
[14]
Bulur O,Dal K,Ertugrul DT, et al.Renal function improves with the treatment of hypothyroidism[J]. Endocr Res, 2017, 42(3): 246-251.
[1] 陈建国, 芦金飞, 刘晨迪, 阮定波. 孕妇甲状腺超声测量参数界定及其与甲状腺功能关系的研究[J]. 中华医学超声杂志(电子版), 2018, 15(11): 822-825.
[2] 玄英华, 岳嵩, 姜玉新, 吴青青. 妊娠期亚临床甲状腺血清学指标异常患者甲状腺超声表现[J]. 中华医学超声杂志(电子版), 2018, 15(03): 213-217.
[3] 陈絮, 詹玉茹, 王纯华. 孕妇ABO血型联合甲状腺功能检测对预测妊娠期糖尿病的临床价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 604-610.
[4] 许瑛杰, 王亚琳, 宋福英, 马丽娟, 黄小兰, 苏改秀, 康闽, 侯俊, 赖建铭. 儿童系统性红斑狼疮患儿甲状腺相关抗体检测的临床意义[J]. 中华妇幼临床医学杂志(电子版), 2022, 18(03): 282-289.
[5] 王妮妮, 陶于洪. 慢性肾脏病与甲状腺功能减退研究现状[J]. 中华妇幼临床医学杂志(电子版), 2019, 15(03): 233-238.
[6] 于海华, 宫建, 王国峰, 于嵩, 唐燕妮. 中孕期孕妇的碘营养状态对心脏电信号的影响[J]. 中华妇幼临床医学杂志(电子版), 2019, 15(01): 8-13.
[7] 张敏, 张蔚, 徐文. 采血时间与新生儿先天性甲状腺功能低下与苯丙酮尿症筛查结果的关系[J]. 中华妇幼临床医学杂志(电子版), 2018, 14(05): 584-588.
[8] 笪东祝, 龙智, 王倩, 乔高昂, 刘俊. 促甲状腺激素受体突变与分化型甲状腺癌相关性的系统评价[J]. 中华普通外科学文献(电子版), 2020, 14(05): 394-400.
[9] 吴艳乐, 郑伟红, 李会, 张进军. 三种甲状旁腺识别和保护技术的效果对比研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(01): 87-90.
[10] 喻涛, 谢博遥, 张伟. 超声刀在甲状腺肿瘤手术中的应用效果及安全性评价[J]. 中华普外科手术学杂志(电子版), 2019, 13(02): 183-185.
[11] 郝少龙, 马纪红, 刘新承, 陈焕杰, 郑海涛, 宋西成. 甲状腺乳头状癌组织TSHR表达与BRAFV600E基因突变的关系研究[J]. 中华普外科手术学杂志(电子版), 2018, 12(06): 468-471.
[12] 王秀利, 武娇, 杨丹艳, 刘继杰, 刘世国. 家族性甲状腺功能减退症的新生儿筛查及治疗转归[J]. 中华临床医师杂志(电子版), 2019, 13(11): 806-810.
[13] 孙明辉, 雷旭, 李金科, 李芳, 杜卫星, 李儒贵, 谭华炳. "一元论"病因诊断在心率矛盾反应中的临床应用[J]. 中华诊断学电子杂志, 2019, 07(01): 59-62.
[14] 王国凤, 惠媛, 王凤力, 闫永鑫. 减重手术对肥胖合并甲状腺功能减退症患者甲状腺功能和左甲状腺素替代治疗剂量影响的Meta分析[J]. 中华肥胖与代谢病电子杂志, 2022, 08(04): 263-270.
[15] 曾文, 邱培才, 高志光. 减重手术对肥胖合并亚临床甲状腺功能减退症影响的Meta分析[J]. 中华肥胖与代谢病电子杂志, 2019, 05(02): 90-95.
阅读次数
全文


摘要